A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults with Non-Small Cell Lung Cancer
Imugene Limited
Imugene Limited
Multitude Therapeutics Inc.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
National Cancer Institute (NCI)
National Cancer Institute (NCI)